Study to Determine the Prevalence of Homologous Recombination Deficiency Among Women With Newly Diagnosed, High-grade, Serous or Endometrioid Ovarian, Primary Peritoneal, and/or Fallopian Tube Cancer

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Country	Location
Kuwait	Kuwait City, Kuwait
Oman	Muscat, Oman
Qatar	Doha, Qatar
Russia	Arkhangelsk, Russia
Russia	Belgorod, Russia
Russia	Chelyabinsk, Russia
Russia	Irkutsk, Russia
Russia	Krasnoyarsk, Russia
Russia	Moscow, Russia
Russia	Nizhniy Novgorod, Russia
Russia	Rostov-on-Don, Russia
Russia	Saint Petersburg, Russia
Russia	Tomsk, Russia
Russia	Tula, Russia
Russia	Tyumen, Russia
Russia	Ufa, Russia
Russia	Yaroslavl, Russia
Russia	Yuzhno-Sakhalinsk, Russia
Russia, Moscow region	Balashikha, Moscow region, Russia
Russia, Moscow region	Istra settlement, Moscow region, Russia
Russia, Moscow region	Kolomna, Moscow region, Russia
Saudi Arabia	Jeddah, Saudi Arabia
Saudi Arabia	Makka, Saudi Arabia
United Arab Emirates	Alain, United Arab Emirates